Mechanism of Action
Mu-Opioid Receptor Selectivity
Endomorphins bind MOR with extraordinarily high affinity and selectivity (>4000-fold selectivity over delta and kappa receptors), exceeding all other endogenous opioids. MOR activation through Gi/Go coupling inhibits adenylyl cyclase, activates GIRK channels, and reduces voltage-gated calcium channel activity. This hyperpolarizes neurons in pain circuits (periaqueductal gray, spinal dorsal horn) and limbic reward circuits, producing analgesia and mild euphoria.
Distribution and Physiological Roles
Endomorphin-1 (primarily supraspinal) modulates stress-related analgesia, immune function, and neuroendocrine responses including GH release. Endomorphin-2 (primarily spinal) mediates spinal analgesia and modulates autonomic function. Both inhibit substance P and cgrp/" class="wiki-internal-link">CGRP release from primary afferents, suppressing nociceptive neurotransmission at multiple levels.
Research Summary
Analgesia
AnimalBoth endomorphins produce potent supraspinal and spinal analgesia in rodent models. Endomorphin-2 administered intrathecally produces analgesia with less respiratory depression than morphine at equi-analgesic doses in some studies, suggesting a potential therapeutic advantage. Endomorphin analogs with metabolic stability are being developed as non-addictive analgesics.
Endomorphin Analogs
AnimalThe rapid degradation of native endomorphins by peptidases has driven development of metabolically stable analogs with beta-amino acids, D-amino acid substitutions, and C-terminal modifications. Some analogs show peripheral MOR restriction, separating analgesia from CNS-mediated addiction and side effects. Peripherally restricted endomorphin analogs are being evaluated as non-addictive visceral analgesics.
Immune and Neuroendocrine Effects
AnimalMOR on immune cells mediates endomorphin-induced immunomodulation, including modulation of NK cell activity, cytokine production, and T-cell function. Endomorphin-1 stimulates GH release through hypothalamic MOR activation, and modulates HPA axis reactivity. These neuroendocrine and immune effects suggest roles beyond pain modulation.
Calculate your Endomorphin dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Spinal analgesia research | 1-100 nmol | Single intrathecal injection | Intrathecal (animal) |
| Supraspinal analgesia | 1-100 nmol | Single ICV injection | ICV (animal) |
| Peripheral pain research | 1-10 nmol/kg | Single or repeated SC | Subcutaneous (animal) |
Native endomorphins are very rapidly degraded. Research uses freshly prepared solutions. Analog development addresses stability limitations.
Interactions
Safety Profile
Endomorphins share the safety concerns of all MOR agonists: respiratory depression, constipation, sedation, and addiction potential at pharmacological doses. Their extreme MOR selectivity compared to morphine may translate to different side effect profiles. Peripherally restricted analogs aim to maintain analgesia while reducing CNS-mediated addiction and respiratory depression. Native endomorphins' rapid degradation limits systemic accumulation with peripheral administration.
References
- [1]Zadina JE, et al. A potent and selective endogenous agonist for the mu-opiate receptor. Nature. 1997;386(6624):499-502.
- [2]Janecka A, et al. Endomorphins and related opioid peptides. Vitamins Hormones. 2004;68:349-373.
- [3]Fichna J, et al. Endomorphins and related opioid peptides: a growing research field. Peptides. 2007.